Dr. Navakanth Gorrepati, MD

Dr. Gorrepati practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Gorrepati's NPI, 1346455599, was assigned on May 11, 2007. Dr. Gorrepati graduated from Sri Venkatesvara Medical College NTR in 2003. Dr. Gorrepati holds Texas license P1314.

Dr. Gorrepati's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Gorrepati's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Gorrepati to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gorrepati practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gorrepati's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gorrepati is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gorrepati's licenses on file in 3 states: Texas, Michigan and Missouri.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, colonoscopy, gastroduodenitis, gastroenteritis, gastrointestinal bleeding and hepatitis c among the conditions Dr. Gorrepati treats.

CMS data shows 864 Medicare services from Dr. Gorrepati across 17 procedure codes in 2024, for 333 Medicare patients. Medicare paid $70,152 for them.

CMS counts 333 Medicare patients who saw Dr. Gorrepati in 2024. The largest group is 65 to 74, with 155 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gorrepati's median patient age at 64, with 56% women.

In 2024, Dr. Gorrepati wrote 933 Medicare Part D claims for 255 patients. 76% of them were for generic drugs. CMS names the drug for 808 of them, across 13 drugs with 11 or more claims each, at $123,313 in total drug cost. In 2023, CMS named 784 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gorrepati for performance year 2024, reported individually. Dr. Gorrepati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gorrepati as offering telehealth. CMS counts 420 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gorrepati, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Gorrepati.

CMS Open Payments shows 233 general payments to Dr. Gorrepati from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Boston Scientific Corporation paid the most, $2,348.

Dmand AI lists 1 award for Dr. Gorrepati.

Dr. Gorrepati graduated from Sri Venkatesvara Medical College NTR in 2003.

Dr. Gorrepati is in network with 20 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.